세포 동역학, 통합
US ˙ NasdaqGS ˙ US23282W6057

SecurityCYTK / Cytokinetics, Incorporated
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC ownership in CYTK / Cytokinetics, Incorporated

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Cytokinetics, Incorporated (US:CYTK) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 29,550 shares of Cytokinetics, Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (CYTK) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 0 -29,550 -100.00 0 -100.00
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -29,550 0
2023-09-21 2022-06-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 29,550 29,550 1,161 0.0096
2022-08-15 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 29,550 29,550 1,161 0.0091
2023-09-21 2022-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 0 -10,000 -100.00 0 -100.00
2022-05-16 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -10,000 0
2023-09-21 2021-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 10,000 -62,500 -86.21 456 -82.44 0.0027
2022-02-14 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 10,000 -62,500 456 0.0024
2023-09-21 2021-09-30 13F/A-2 CYTOKINETICS COM NEW 23282W605 72,500 72,500 2,591 0.0189
2021-12-17 2021-09-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 72,500 72,500 2,591 0.0178
2021-11-15 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 72,500 72,500 2,591 0.0167
2023-09-21 2020-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 0 -48,624 -100.00 0 -100.00
2021-02-16 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -48,624 0
2020-11-13 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 48,624 48,624 1,053 0.0117
2019-05-15 2019-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -16,030 -100.00 0 -100.00
2019-02-14 2018-12-31 13F CYTOKINETICS COM NEW 23282W605 16,030 4,830 43.12 101 -8.18 0.0008
2018-11-14 2018-09-30 13F CYTOKINETICS COM NEW 23282W605 11,200 11,200 110 0.0007
2016-05-11 2016-03-31 13F CYTOKINETICS COM NEW 23282W605 0 0 0 0.0000
2016-02-12 2015-12-31 13F CYTOKINETICS COM NEW 23282W605 0 0 0 0.0000
2015-11-13 2015-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -4,417 -100.00 0 -100.00
2015-08-18 2015-06-30 13F CYTOKINETICS COM NEW 23282W605 4,417 4,417 0.00 30 0.0002
2014-08-14 2014-06-30 13F CYTOKINETICS COM NEW 23282W605 0 -36,692 -100.00 0 -100.00
2014-05-16 2014-03-31 13F CYTOKINETICS COM NEW 23282W605 36,692 36,692 349 0.0034
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2020-12-31 13F/A CYTOKINETICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F CYTOKINETICS COM NEW Put 0 0 n/a n/a n/a
2020-11-13 2020-09-30 13F CYTOKINETICS COM NEW Put 400 9 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.